Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
16,008
Total Claims
$498K
Drug Cost
355
Beneficiaries
$1,404
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 712 Family Medicine providers
-89%
Opioid rate vs peers
0.4% vs 3.5% avg
+72%
Cost per patient vs peers
$1,404 vs $816 avg
+20%
Brand preference vs peers
7.5% vs 6.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.4%
Opioid Rate
62
Opioid Claims
$249
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,181 claims · $341K
Generic: 14,599 claims · $150K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 104 | $60K |
| Insulin Glargine,hum.Rec.Anlog | 105 | $50K |
| Insulin Nph Hum/Reg Insulin Hm | 162 | $43K |
| Rivaroxaban | 36 | $24K |
| Insulin Lispro | 55 | $22K |
| Levothyroxine Sodium | 174 | $12K |
| Dulaglutide | 11 | $11K |
| Insulin Lispro Protamin/Lispro | 18 | $9,031 |
| Fluticasone Propionate | 27 | $8,634 |
| Levothyroxine Sodium | 656 | $8,567 |
| Atorvastatin Calcium | 1,234 | $8,415 |
| Empagliflozin | 12 | $7,335 |
| Sitagliptin Phos/Metformin Hcl | 13 | $7,051 |
| Colchicine | 12 | $6,066 |
| Glipizide | 546 | $5,606 |
Prescribing Profile
Patient Profile
78
Avg Age
59%
Female
1.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About